GLP-1 drugs may offer a better option than aspirin for people hoping to prevent colorectal cancer
Doses are adjusted based on what youre noticing in training, sleep, and recovery
Short-acting GLP-1 RAs, exenatide and lixisenatide, are associated with a transient (112 h) mean placebo- and baseline-adjusted 24-h HR increase of 13 beats per minute (bpm)
By Emily Rodriguez, RDN, CSSD|Source reviewed by FormBlends Editorial Standards Team|| Source Reviewed Written by Emily Rodriguez, RDN, CSSD Checked against primary sources by FormBlends Editorial Standards Team In This Article This article is part of our Quick Answers collection
In doing so, they also interact with the brains reward system, which researchers say may help explain some of the reported changes